✦ LIBER ✦

Serum iron level as an indicator for inflammation in dogs and cats

✍ Scribed by S. Neumann

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 163 KB
Volume: 12
Category: Article
ISSN: 1618-5641
DOI: 10.1007/s00580-003-0481-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of CA19-9 may be as an indi

Serum levels of CA19-9 may be as an indicator for metastases in patients with non-small cell lung cancer

✍ Xing’an Liu; Guoyong Shan; Song Zhang; Kaijian Lei 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 314 KB

A longitudinal study of the hyaluronan l

A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease

✍ Inger Marie S. Dahl; Øyvin Pleym Solheim; Bjørn Erikstein; Erwin Müller 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Evaluation of 31P NMR spectroscopy as an

Evaluation of 31P NMR spectroscopy as an indicator of chemically induced hepatic toxicity in the rat: Comparison with serum enzyme levels and pathology

✍ G. S. Sandhu; N. C. Gonnella; J. C. Kapeghian; A. F. Plocinski; J. Plutchok; M. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Tbe pmgresion of carbon tetrachloride-induced liver damage, determined by "P NMR spectroscopy, was compared with selected serum enzyme and btollogiepI changes in rats. ATP levels declined as early 88 8 h pOst-CQ addahtm tion, with partial recovery observed at l a b . Tbe results show that ATP r e d

Ratio of baseline erythropoietin (EPO) l

Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients

✍ Navapun Charuruks; Narin Voravud; Wacharee Limpanasithikul 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Purpose: Recently, recombinant human erythropoietin (rhEPO) was introduced for the management of anemia in malignancy. To identify an indicator for a favourable response to rhEPO, 28 anaemic cancer patients undergoing chemotherapy and treated with rhEPO were evaluated. Methods: Patients